Clinical Trials Logo

Tranexamic Acid clinical trials

View clinical trials related to Tranexamic Acid.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03085394 Terminated - Tranexamic Acid Clinical Trials

Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery

PHORBBS
Start date: September 1, 2017
Phase: Phase 3
Study type: Interventional

Prophylactic use of tranexamic acid to reduce intra and postoperative bleeding in primary sleeve gastrectomy procedures will be studied.

NCT ID: NCT02753816 Terminated - Burn Clinical Trials

TXA Study in Major Burn Surgery

Start date: April 2016
Phase: N/A
Study type: Interventional

Major surgery can result in blood loss that can require a blood transfusion during and/or after surgery. Tranexamic acid (TXA) is a medication that was first introduced in the 1960's as a treatment for heavy menstrual bleeding. Over the past 20 years, it has been used and studied in patients undergoing open-heart surgery, liver transplantation, and urologic surgery. Investigators believe tranexamic acid may possibly decrease bleeding related to major burn surgery, resulting in reduced blood loss, lower blood transfusion rates, and possibly decreased hospital costs related to your stay. In this study, prior to each surgical procedure to treat the participants burn injury, the participant will receive either the drug tranexamic acid or placebo. The placebo is a liquid that looks like the tranexamic acid medicine, but does not have any active ingredient in it. In this study, both the tranexamic acid and the placebo are considered research.